Romeo Lledo - PT Lippo Senior Executive Officer - Siloam Hospitals
PTLKF Stock | USD 0 0.00 0.00% |
Executive
Dr. Romeo Fernandez Lledo serves as Senior Executive Officer Siloam Hospitals of PT Lippo Karawaci Tbk. He is a Certified Public Accountant in the Philippines since 1977. He obtained Management Development Program certification from the Asian Institute of Management, Philippines in 1986. He has years of experience as Public Accountant in trade management and industries. He joined PT Siloam International Hospitals Tbk in 2010 as Director. Until 2014, he served as President Director and Independent Director of PT Siloam International Hospitals Tbk, and now serves as Vice President Commissioner.
Age | 61 |
Professional Marks | Ph.D |
Phone | 62 21 2566 9000 |
Web | https://www.lippokarawaci.co.id |
PT Lippo Management Efficiency
PT Lippo's management efficiency ratios could be used to measure how well PT Lippo manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Blake Clardy | Digitalbridge Group | N/A | |
David Kotansky | Colliers International Group | N/A | |
Fiona DSilva | Kennedy Wilson Holdings | N/A | |
Matthew Bouw | Cushman Wakefield plc | N/A | |
Jeff Green | Cushman Wakefield plc | N/A | |
Bernardo Gibsone | Digitalbridge Group | 65 | |
Sam HarveyJones | Colliers International Group | N/A | |
CPV FAPI | Colliers International Group | N/A | |
Dean Criares | Digitalbridge Group | N/A | |
Leslie Golden | Digitalbridge Group | N/A | |
CPA CGA | Colliers International Group | 56 | |
Colin Wilson | Cushman Wakefield plc | N/A | |
Mark Cortell | Marcus Millichap | N/A | |
Kristen Whealon | Digitalbridge Group | N/A | |
Christopher Ireland | Jones Lang LaSalle | 45 | |
Stephen Stryker | Digitalbridge Group | N/A | |
Lynda Cralli | Colliers International Group | N/A | |
Durgesh Sharma | Colliers International Group | N/A | |
Mary Bilbrey | Jones Lang LaSalle | 56 | |
Charlotte Williams | Colliers International Group | N/A | |
Croft Young | CBRE Group Class | N/A |
Management Performance
Return On Equity | -0.13 | |||
Return On Asset | 0.0078 |
PT Lippo Karawaci Leadership Team
Elected by the shareholders, the PT Lippo's board of directors comprises two types of representatives: PT Lippo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PTLKF. The board's role is to monitor PT Lippo's management team and ensure that shareholders' interests are well served. PT Lippo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PT Lippo's outside directors are responsible for providing unbiased perspectives on the board's policies.
Bartholomeus Toto, Senior Executive Officer - Lippo Homes | ||
Tanri Abeng, Independent Commissioner | ||
Heok Lee, Director | ||
Marshal Tissadharma, Director | ||
Julie McCaughan, Senior Executive Officer - Siloam Hospitals | ||
Ninik Nathan, Director | ||
Johanes Jany, Director | ||
Soerjadi Soedirdja, Vice President Commissioner, Independent Commissioner | ||
Farid Harianto, Independent Commissioner | ||
Jenny Kuistono, Corporate Secretary and Director | ||
Muladi, Independent Commissioner | ||
Ketut Wijaya, Pres Director | ||
Anthony Ross, Senior Executive Officer - Hotels & Hospitality | ||
Viven Sitiabudi, Commissioner | ||
Alwi Sjaaf, Independent Director | ||
Gordon Benton, Senior Executive Officer | ||
Budi Legowo, Senior Executive Officer - Siloam Hospitals | ||
Sri Handoyo, Corporate Secretary | ||
William Utama, IR Contact Officer | ||
Chong Meow, Senior Executive Officer | ||
H Sutiyoso, Commissioner | ||
Eddy Mumin, Senior Executive Officer - Lippo Malls | ||
Caroline Riady, Senior Executive Officer - Siloam Hospitals | ||
Theo Sambuaga, President Commissioner, Independent Commissioner | ||
Marshall Tissadharma, Senior Executive Officer - Lippo Malls | ||
Romeo Lledo, Senior Executive Officer - Siloam Hospitals | ||
Norita Alex, Director - Talent Administration | ||
Surjadi Soedirdja, Vice President Commissioner, Independent Commissioner | ||
Kooi Choo, Director | ||
Grace Indradjaja, Senior Executive Officer - Siloam Hospitals | ||
Dion Leswara, Chief Director | ||
Chee Chan, Director | ||
Edward Ng, Senior Executive Officer - Lippo Malls | ||
Rudy Halim, COO Director | ||
Krishnadi Kartawidjaja, Chief Devel | ||
Tjokro Libianto, Director | ||
Rahmawaty, Director | ||
Andi Anzhar, Senior Executive Officer - Lippo Homes | ||
Bret Ginesky, Head Relations | ||
Donny Susanto, Chief Controller | ||
John Riady, CEO Director | ||
Surya CFA, Chief Director | ||
Benny Djie, Commissioner | ||
Budiraharjo Legowo, Senior Executive Officer - Siloam Hospitals | ||
Agum Gumelar, Independent Commissioner | ||
Juergen Fischer, Senior Executive Officer - Hotels & Hospitality | ||
Kah Hong, Controller | ||
Anwar Salim, Senior Executive Officer - Lippo Malls | ||
Danang Jati, Head Communications | ||
Sunil Ithikatt, Senior Executive Officer - Hotel | ||
Anang Prayudi, Senior Executive Officer - Siloam Hospitals | ||
Sugianganto Budisuharto, Senior Executive Officer - Siloam Hospitals | ||
Gershu Chandy, Senior Executive Officer | ||
Siek Yohandra, Senior Executive Officer - Lippo Homes | ||
Jopy Rusli, Chief Officer | ||
Hendra Sidin, Vice President Director | ||
Richard Setiadi, Director | ||
Wijaya Subekti, Director | ||
Mark Wong, Investor Relations Director | ||
Meng Phua, CFO Director | ||
Andry, Senior Executive Officer - Siloam Hospitals | ||
Ivan Budiono, Director | ||
Susan Tedjadinata, Senior Executive Officer - Lippo Homes | ||
Marshall Martinus, Senior Executive Officer - Lippo Malls | ||
Purnomo Utoyo, Senior Executive Officer - Lippo Homes |
PTLKF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is PT Lippo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.13 | |||
Return On Asset | 0.0078 | |||
Profit Margin | (0.20) % | |||
Current Valuation | 1.54 B | |||
Shares Outstanding | 70.8 B | |||
Shares Owned By Insiders | 55.70 % | |||
Shares Owned By Institutions | 4.00 % | |||
Price To Earning | 19.00 X | |||
Price To Book | 0.54 X | |||
Price To Sales | 0.62 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PT Lippo Karawaci using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PT Lippo Karawaci. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for PTLKF Pink Sheet analysis
When running PT Lippo's price analysis, check to measure PT Lippo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Lippo is operating at the current time. Most of PT Lippo's value examination focuses on studying past and present price action to predict the probability of PT Lippo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Lippo's price. Additionally, you may evaluate how the addition of PT Lippo to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |